Fragment analysis of the p53 gene in ovarian tumors

Clinical Biochemistry

Volumn 31, Issue 7, 1998, Pages 551-553

  Lianidou, Evriklia S ^a,c   Angelopoulou, Katerina ^a,b   Katsaros, Dionyssios ^d   Durando, Antonio ^d   Massdario, Marco ^d   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; CELL GROWTH; DNA DAMAGE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; OVARY TUMOR; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR SUPPRESSOR GENE;

FEMALE; GENES, P53; HUMANS; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION;

EID: 0032191863     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00061-7     Document Type: Article

References (15)

1. Lane D.P. p53, guardian of the genome. Nature. 358:1992;15-16.
2. Vogelstein B., Kinzler K.W. p53 function and dysfunction. Cell. 70:1992;523-526.
3. Velculescu V.E., El-Deiry W.S. Biological and clinical importance of the p53 tumor suppressor gene. Clin Chem. 42:1996;858-868.
4. Levesque M.A., Katsaros D., Yu H., et al. Mutant p53 overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma. Cancer. 75:1995;1327-1338.
5. Baker S.J., Preisinger A.C., Jessup J.M., et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50:1990;7717-7722.
6. Prosser J., Thompson A.L., Cranston G., Evans H.J. Evidence that p53 behaves as a tumor suppressor gene in sporadic breast tumors. Oncogene. 5:1990;1573-1579.
7. Takahashi T., Nau N.M., Chiba I., et al. p53 - a frequent target for genetic abnormalities in lung cancer. Science. 246:1989;491-494.
8. Mazars R., Pujol P., Maudelonde T., Jeanteur P., Theillet C. p53 mutations in ovarian cancer - a late event. Oncogene. 6:1991;1685-1690.
9. Mashiyama S., Murakami Y., Yoshimoto T., Sekiya T., Hayashi K. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene. 6:1991;1313-1318.
10. Jego N., Thomas G., Hamelin R. Short direct repeats flanking deletions and duplicating insertions in p53 gene in human cancers. Oncogene. 8:1993;209-213.
11. Runnebaum I.B., Tong X.W., Moebus V., Heilmann V., Keiback D.G., Kreienberg R. Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines. Hum Genet. 93:1994;620-624.
12. Ausubel FM, Brent R, Kingston RE, et al. (Eds.) Current Protocols in Molecular Biology. Volumes 1;2.2.1-2.2.2. New York: John Wiley & Sons, Inc., 1995.
13. Angelopoulou K, Diamandis EP. Identification of deletions and insertions in the p53 gene using multiplex PCR and high resolution fragment analysis: application to breast and ovarian tumors. J Clin Lab Anal (in press).
14. Angelopoulou K, Yu H, Bharaj BS, Giai M, Diamandis EP. p53 gene mutation, tumor p53 protein overexpression and serum p53 autoantibody generation in patients with breast cancer. Int J Cancer (submitted 1998).
15. Toguchida J., Yamaguchi T., Ritchie B., et al. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res. 52:1992;6194-6199.